SynthesisJournal of neurology2026

Efficacy and safety of monoclonal antibodies in the treatment of relapsing remitting multiple sclerosis: a systematic review.

Ana Avedillo-Salas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.